Gilead and insitro Announce Strategic Collaboration to Discover and Develop Novel Therapies for NASH Read more
Lynparza approved in EU for the treatment of germline BRCA-mutated HER2-negative advanced breast cancer Read more
WuXi Biologics and NBE-Therapeutics Announce Comprehensive ADC Development and Manufacturing Partnership Read more
Regeneron and Alnylam Announce Broad Collaboration to Discover, Develop and Commercialize RNAi Therapeutics Focused on Ocular and CNS Diseases Read more
Novartis receives FDA approval for Mayzent (siponimod), the first oral drug to treat secondary progressive MS with active disease Read more
Merck To Collaborate with GenScript to Accelerate Cell and Gene Therapy Industrialization in China Read more